CTCBIO Inc (060590) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.079x

Based on the latest financial reports, CTCBIO Inc (060590) has a cash flow conversion efficiency ratio of 0.079x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩5.64 Billion ≈ $3.82 Million USD) by net assets (₩71.75 Billion ≈ $48.62 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 060590 company net worth for the company's overall valuation and market capitalisation.

CTCBIO Inc - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how CTCBIO Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

CTCBIO Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of CTCBIO Inc ranked by their cash flow conversion efficiency. Explore CTCBIO Inc earnings quality ratio to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Chia Her Industrial Co Ltd
TW:1449
-0.040x
Brand X Co. Ltd.
KQ:337930
-0.020x
Alchemy Investments Acquisition Corp 1 Class A Ordinary Shares
NASDAQ:ALCY
1.504x
Nyquest Technology Co Ltd
TWO:6494
0.132x
FST Corp. Ordinary Shares
NASDAQ:KBSX
0.414x
Great Computer
TWO:8047
-0.003x
Oswal Agro Mills Limited
NSE:OSWALAGRO
0.081x
Plastikkart Akilli Kart Iletisim Sistemleri Sanayi ve Ticaret AS
IS:PKART
0.157x

Annual Cash Flow Conversion Efficiency for CTCBIO Inc (2013–2024)

The table below shows the annual cash flow conversion efficiency of CTCBIO Inc from 2013 to 2024. View current stock price of CTCBIO Inc for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ₩69.62 Billion
≈ $47.18 Million
₩4.50 Billion
≈ $3.05 Million
0.065x -40.69%
2023-12-31 ₩75.44 Billion
≈ $51.13 Million
₩8.22 Billion
≈ $5.57 Million
0.109x -42.66%
2022-12-31 ₩95.96 Billion
≈ $65.03 Million
₩18.22 Billion
≈ $12.35 Million
0.190x +150.02%
2021-12-31 ₩85.01 Billion
≈ $57.61 Million
₩6.46 Billion
≈ $4.38 Million
0.076x +1036.38%
2020-12-31 ₩76.32 Billion
≈ $51.72 Million
₩510.09 Million
≈ $345.68K
0.007x -70.18%
2019-12-31 ₩74.74 Billion
≈ $50.65 Million
₩1.68 Billion
≈ $1.14 Million
0.022x +178.74%
2018-12-31 ₩86.87 Billion
≈ $58.87 Million
₩-2.47 Billion
≈ $-1.68 Million
-0.028x -813.17%
2017-12-31 ₩73.98 Billion
≈ $50.14 Million
₩295.30 Million
≈ $200.12K
0.004x -94.71%
2016-12-31 ₩90.89 Billion
≈ $61.60 Million
₩6.86 Billion
≈ $4.65 Million
0.076x +420.86%
2015-12-31 ₩99.14 Billion
≈ $67.19 Million
₩1.44 Billion
≈ $974.04K
0.014x +456.42%
2014-12-31 ₩85.49 Billion
≈ $57.94 Million
₩-347.74 Million
≈ $-235.66K
-0.004x -113.69%
2013-12-31 ₩92.23 Billion
≈ $62.50 Million
₩2.74 Billion
≈ $1.86 Million
0.030x --

About CTCBIO Inc

KQ:060590 Korea Biotechnology
Market Cap
$49.26 Million
₩72.68 Billion KRW
Market Cap Rank
#22031 Global
#1351 in Korea
Share Price
₩3040.00
Change (1 day)
-1.78%
52-Week Range
₩2700.00 - ₩7160.00
All Time High
₩18000.00
About

CTCBIO Inc. provides various pharmaceutical products in South Korea and internationally. The company offers animal and human pharmaceuticals; feed additives and ingredients; and functional food products. It also provides cardiovascular, gastrointestinal, osteoporosis, antibiotic, smoking cessation, antifungal and antiviral, antiepileptic, allergic rhinitis, dermatology and genito-urinory, allergi… Read more